Dr. Andrew Feigin, Chair of the Huntington Study Group joined us to usher in 2020 and a new year of HD Insights Podcasts. Dr. Feigin is a professor of Neurology at NYU Langone Health and co-director of the Marlene and Paolo Fresco Institute for Parkinson’s and Movement Disorders. He has been involved in HD research since his participation in the Venezuela Collaborative Research Group, which isolated the HD gene 25 years ago. In this episode, Dr. Feigin shares what the experience in Venezuela was like, his tenure at North Shore University Hospital on Long Island setting up a Huntington's disease clinic, and current initiatives he's leading with the Huntington Study Group. We also get an update on the SIGNAL trial from Dr. Feigin, who serves as the Principal Investigator on that trial.  To learn more about the Huntington Study Group and their current clinical trials and research, visit www.huntingtonstudygroup.org